← Alle mensen

CE

Carles Escriu

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Gevorderd NSCLC.

The New England journal of medicine · 1 januari 2026

Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small Cell Lung Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 september 2025

Genomische alteraties en hersenmetastasen bij gevorderd NSCLC: systematische review

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2023-12